© 2021 MJH Life Sciences and Neurology Live. All rights reserved.
© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
January 17, 2021
The neurologist from the Comprehensive Epilepsy Care Center for Children and Adults, in St. Louis, Missouri, discussed the different medications that cenobamate was used with.
January 16, 2021
The chief medical officer of Cerevel Therapeutics detailed phase 2 data of its investigational agent tavapadon, which has been studied in patients with Parkinson disease.
Maha Radhakrishnan, MD, the Group SVP and chief medical officer at Biogen, discussed the collaborative study between Biogen and Apple that’s expected to kick off later this year.
January 15, 2021
The FDA previously declined to approve de novo classification in April 2019.
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 15, 2021.
No devices performed better than polysomnography, but the researchers believe they warrant further testing.
Trevor J. Resnick, MD, reviews data presented at the American Epilepsy Society (AES) Annual Meeting 2020.
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Jacqueline French, MD.
January 14, 2021
William Rosenfeld, MD, discusses the decreases his team observed in concomitant medication use with cenobamate in patients with focal seizures.